(2R)-6-chloro-2-methyl-8-(trifluoromethyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2R)-6-chloro-2-methyl-8-(trifluoromethyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one
• 化学式: C₉H₆ClF₃N₂O₂
• 分子量: 266.607
• InChiKey: JYGMLBVGTRLLTO-GSVOUGTGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  51.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  三氟甲烷磺酰氯 、 (R)-6-chloro-2-methyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one 在 Ir(dFppy)₃ 、 dipotassium hydrogenphosphate 作用下， 以 乙腈 为溶剂， 生成 (2R)-6-chloro-2-methyl-8-(trifluoromethyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one 、 (2R)-6-chloro-2-methyl-7-(trifluoromethyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one
  参考文献：
  名称：

  [EN] BENZOXAZINONE DERIVATIVES AND ANALOGUES THEREOF AS MODULATORS OF TNF ACTIVITY
  [FR] DÉRIVÉS DE BENZOXAZINONE ET LEURS ANALOGUES EN TANT QUE MODULATEURS DE L'ACTIVITÉ DU TNF

  摘要：

  一系列替代的3,4-二氢-2H-1,4-苯并噁嗪-3-酮衍生物及其类似物，作为人类TNFα活性的有效调节剂，因此对于治疗和/或预防各种人类疾病具有益处，包括自身免疫和炎症性疾病；神经和神经退行性疾病；疼痛和伤害感知性疾病；心血管疾病；代谢性疾病；眼部疾病；以及肿瘤性疾病。

  公开号：

  WO2016198400A1

文献信息

• Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
  申请人：UCB Biopharma SPRL

  公开号：US10287299B2

  公开（公告）日：2019-05-14

  A series of substituted 3,4-dihydro-2H-.1,4-benzoxazin-3-one derivatives, and analogs thereof, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neuradegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

  一系列取代的 3,4-二氢-2H-.1,4-苯并恶嗪-3-酮衍生物及其类似物是人类 TNFa 活性的强效调节剂，因此可用于治疗和/或预防各种人类疾病，包括自身免疫和炎症性疾病、神经和神经退行性疾病、疼痛和痛觉失调、心血管疾病、代谢性疾病、眼部疾病和肿瘤疾病。
• FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
  申请人：UCB Biopharma SPRL

  公开号：EP3080115B1

  公开（公告）日：2019-05-08
• Fused Imidazole and Pyrazole Derivatives As Modulators of TNF Activity
  申请人：UCB BIOPHARMA SPRL

  公开号：US20160297837A1

  公开（公告）日：2016-10-13

  A series of substituted benzimidazole, imidazo[1,2-a]pyridine and pyrazolo[1,5-a]pyridine derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
• Benzoxazinone Derivatives and Analogues Thereof as Modulators of TNF Activity
  申请人：UCB Biopharma SPRL

  公开号：US20180134728A1

  公开（公告）日：2018-05-17

  A series of substituted 3,4-di-hydro-2H-.1,4-benzoxazin-3-one derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
• US9868749B2
  申请人：——

  公开号：US9868749B2

  公开（公告）日：2018-01-16